A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

BACKGROUND: There is uncertainty regarding the safety and effectiveness of direct oral anticoagulant agents in patients with antiphospholipid syndrome (APS). We performed a multicenter feasibility study to examine our ability to identify and obtain consent from eligible APS patients and to obtain 95...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pilot Feasibility Stud
Main Authors: Legault, Kimberly, Blostein, Mark, Carrier, Marc, Khan, Susan, Schulman, Sam, Shivakumar, Sudeep, Wu, Cynthia, Crowther, Mark A.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7183116/
https://ncbi.nlm.nih.gov/pubmed/32346486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-020-00594-1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki